Is LB Pharmaceuticals Inc Common Stock profitable?

LB Pharmaceuticals Inc Common Stock is not currently profitable: it reported a net loss of $39.0M over the trailing twelve months.

What is LB Pharmaceuticals Inc Common Stock's earnings per share?

LB Pharmaceuticals Inc Common Stock's diluted EPS over the trailing twelve months is $-30.07.

Where does LB Pharmaceuticals Inc Common Stock's income statement data come from?

Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

LB Pharmaceuticals Inc Common Stock LBRX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Research and development	$27.97M—	$16.74M—	$8.64M—	$16.88M—	——
General and administrative	$18.11M—	$13.66M—	$13.44M—	$16.03M—	——
Other operating expenses	$46.08M—	$30.4M—	$22.07M—	$32.91M—	——
Total operating expenses	$46.08M—	$30.4M—	$22.07M—	$32.91M—	——
Interest income	$6.53M—	$3.92M—	$1.42M—	$1.1M—	——
Other income (expense), net	$7.14M—	$5.21M—	$3.28M—	$3.49M—	——
Income before income taxes	-$38.95M—	-$25.2M—	-$18.8M—	-$29.43M—	——
Income tax expense	$1K—	$1K—	$1K—	$1K—	——
Net income	-$38.95M+25.4%	-$25.2M+60.1%	-$18.8M—	-$29.43M—	-$52.19M—
Diluted earnings per share	——	——	——	——	——
Basic earnings per share	——	——	——	——	——
Weighted-average shares, diluted	——	——	——	——	——
Weighted-average shares, basic	——	——	——	——	——
Derivatives	——	——	——	——	——
Add: dilutive effect of potential common shares (in shares)	——	——	——	——	——
EBIT	-$38.95M—	-$25.2M—	-$18.8M—	-$29.43M—	——
EBITDA	-$38.63M—	-$24.88M—	-$18.54M—	-$29.22M—	——
EBITDA	-$38.63M—	-$24.88M—	-$18.54M—	-$29.22M—	——
EBIT	-$38.95M—	-$25.2M—	-$18.8M—	-$29.43M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is LB Pharmaceuticals Inc Common Stock profitable?: LB Pharmaceuticals Inc Common Stock is not currently profitable: it reported a net loss of $39.0M over the trailing twelve months.
What is LB Pharmaceuticals Inc Common Stock's earnings per share?: LB Pharmaceuticals Inc Common Stock's diluted EPS over the trailing twelve months is $-30.07.
Where does LB Pharmaceuticals Inc Common Stock's income statement data come from?: Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.